Journals / Journal of the Turkish-German Gynecological Association / 2020 / Cilt: 21 - Sayı: 3

Perinatal outcomes of twenty-five human immunodeficiency virus-infected pregnant women: Hacettepe University experience

Pages
180–186
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

HIV infected womenmay give birth to HIV negative babies with the help of a multidisciplinary team, composed of perinatology, infectious diseases, and pediatricsspecialists. (J Turk Ger Gynecol Assoc 2020; 21: 180-6)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate perinatal outcomes in human immunodeficiency virus (HIV) infected pregnant women in Turkey.Material and Methods: Maternal characteristics, pregnancy complications, laboratory findings including HIV load, CD4 cell count, CD4/CD8ratio, neonatal features and final HIV status of the baby were retrospectively analyzed.Results: The sample included 26 singleton pregnancies, from 25 HIV-infected women.
📊
Key Findings & Data:The ethnicities were Turkish (n=18), East European(n=4), Asian (n=2) and African (n=2).
💡
Conclusion & Impact:HIV infected womenmay give birth to HIV negative babies with the help of a multidisciplinary team, composed of perinatology, infectious diseases, and pediatricsspecialists. (J Turk Ger Gynecol Assoc 2020; 21: 180-6)
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate perinatal outcomes in human immunodeficiency virus (HIV) infected pregnant women in Turkey.Material and Methods: Maternal characteristics, pregnancy complications, laboratory findings including HIV load, CD4 cell count, CD4/CD8ratio, neonatal features and final HIV status of the baby were retrospectively analyzed.Results: The sample included 26 singleton pregnancies, from 25 HIV-infected women. The ethnicities were Turkish (n=18), East European(n=4), Asian (n=2) and African (n=2). The majority (76.9%) was aware of their HIV status before becoming pregnant. Four cases (15.3%) werediagnosed during pregnancy and two (7.8%) at the onset of labor. The results for median HIV viral load, CD4 count, and CD4/CD8 ratio at birthwere 20 copies/mL (0-34 587), 577/mm3 (115-977), and 0.7 (0.1-1.9), respectively. The HIV viral load rate was 5.5% in eighteen women takinganti-retroviral treatment. The rates of gestational diabetes mellitus, gestational hypertension, intrauterine growth restriction, and preterm deliverywere 3.8%, 3.8%, 7.6%, and 8% (numbers are 1;1;2;2), respectively. The mean gestational week at birth was 38 weeks and mean birthweight is2972±329 g. Two babies were congenitally infected with HIV (infection rate of 8.3%). There was one needle-related accident during surgery.Conclusion: Timely diagnosis of HIV infection during pregnancy is important for preventing mother to child transmission. HIV infected womenmay give birth to HIV negative babies with the help of a multidisciplinary team, composed of perinatology, infectious diseases, and pediatricsspecialists. (J Turk Ger Gynecol Assoc 2020; 21: 180-6)

🔖

Cite This Article

ÖZYÜNCÜ, Ö., ÖRGÜL, G., BEKSAÇ, M. S., KARA, A., HALİS, N., YURDAKÖK, M., ÜNAL, S., İNKAYA, A. C., ALP, Ş. (2022). Perinatal outcomes of twenty-five human immunodeficiency virus-infected pregnant women: Hacettepe University experience. Journal of the Turkish-German Gynecological Association, Cilt: 21 - Sayı: 3, 180–186. https://ajindex.com/articles/567413

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sheet UGSF. UNAIDS [online] http://www. unaids. org/sites/default/ files/media_asset. UNAIDS_FactSheet_en pdf. 2016
  2. Whitmore SK, Zhang X, Taylor AW, Blair JM. Estimated number of infants born to HIV-infected women in the United States and five dependent areas, 2006. J Acquir Immune Defic Syndr 2011; 57: 218- 22
  3. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2018
  4. Ozdemir B, Yetkin MA, Bastug A, But A, Aslaner H, Akinci E, et al. Evaluation of epidemiological, clinical, and laboratory features and mortality of 144 HIV/AIDS cases in Turkey. HIV Clin Trials 2018; 19: 69-74
  5. Tümer A, Serhat Ü. HIV/AIDS epidemiyolojisi ve korunma. Sosyal Politika Çalışmaları Dergisi 2001:4
  6. Çerci P, İnkaya AÇ, Alp Ş, Tümer A, Ünal S. Evaluation of 255 HIV/ AIDS cases: Hacettepe cohort, Ankara, Turkey. Mikrobiyol Bul 2016; 50: 94-103
  7. Centers for Disease Control (CDC). Unexplained immunodeficiency and opportunistic infections in infants--New York, New Jersey, California. MMWR Morb Mortal Wkly Rep 1982; 31: 665-7
  8. Raffe SF, Savage C, Perry LA, Patel A, Keith T, Howell R, et al. The management of HIV in pregnancy: A 10-year experience. Eur J Obstet Gynecol Reprod Biol 2017; 210: 310-3
  9. Townsend CL, Byrne L, Cortina-Borja M, Thorne C, de Ruiter A, Lyall H, et al. Earlier initiation of ART and further decline in motherto- child HIV transmission rates, 2000-2011. AIDS 2014; 28: 1049-57
  10. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-80
  11. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002; 29: 484-94
  12. Townsend CL, Willey BA, Cortina-Borja M, Peckham CS, Tookey PA. Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007. AIDS 2009; 23: 519-24
  13. Landesman SH, Kalish LA, Burns DN, Minkoff H, Fox HE, Zorrilla C, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to ch